IL50250A0 - Pharmaceutical base salts of a polymer containing acid - Google Patents
Pharmaceutical base salts of a polymer containing acidInfo
- Publication number
- IL50250A0 IL50250A0 IL50250A IL5025076A IL50250A0 IL 50250 A0 IL50250 A0 IL 50250A0 IL 50250 A IL50250 A IL 50250A IL 5025076 A IL5025076 A IL 5025076A IL 50250 A0 IL50250 A0 IL 50250A0
- Authority
- IL
- Israel
- Prior art keywords
- polymer containing
- containing acid
- base salts
- pharmaceutical base
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3529675 | 1975-08-27 | ||
GB3529575A GB1563390A (en) | 1975-08-27 | 1975-08-27 | Pharmaceutical products |
GB2396376 | 1976-06-10 | ||
GB2396276 | 1976-06-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL50250A0 true IL50250A0 (en) | 1976-10-31 |
IL50250A IL50250A (en) | 1980-01-31 |
Family
ID=27448608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL50250A IL50250A (en) | 1975-08-27 | 1976-08-12 | Sustained release compositions comprising slats of pharmaceutically acitve bases with polymers containing acid groups |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS5254014A (en) |
CH (1) | CH621940A5 (en) |
DE (1) | DE2636559C2 (en) |
IL (1) | IL50250A (en) |
SE (1) | SE7609339L (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6056684B2 (en) * | 1977-11-07 | 1985-12-11 | 東興薬品工業株式会社 | eye drops |
GB2013084B (en) * | 1978-01-25 | 1982-07-28 | Alcon Lab Inc | Ophthalmic drug dosage |
HU187313B (en) * | 1980-10-03 | 1985-12-28 | Andras Sugar | Dental cosmetic prparation |
IL61721A (en) * | 1980-12-16 | 1984-03-30 | Blank Izhak | Nitroglycerin preparations |
US4539199A (en) * | 1981-01-14 | 1985-09-03 | Egyt Gyogyszervegyeszeti Gyar | Sustained release pharmaceutical compositions |
EP0103970A3 (en) * | 1982-08-20 | 1985-05-22 | LAWRENCE, Peter Robin Broughton | Amine salts and products containing them |
AU563054B2 (en) * | 1984-10-24 | 1987-06-25 | Sekisui Kagaku Kogyo Kabushiki Kaisha | Percutaneous tape of isdn |
CA1295941C (en) * | 1985-08-16 | 1992-02-18 | Rajan Bawa | Sustained-release formulation comprising a hydrophobic polymer system |
EP0268680A4 (en) * | 1986-05-29 | 1990-04-10 | Vnii Ispytatel Med Tech | Antitumor film of biodestructible polymers. |
DE19549506C2 (en) * | 1995-03-07 | 1998-07-30 | Richard Prof Dr Sueverkruep | Pharmaceutical or diagnostic dosage form, esp. for ophthalmic use |
US5972326A (en) * | 1995-04-18 | 1999-10-26 | Galin; Miles A. | Controlled release of pharmaceuticals in the anterior chamber of the eye |
US5888494A (en) * | 1996-03-12 | 1999-03-30 | Adolor Corporation | Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith |
DE59707744D1 (en) * | 1996-10-23 | 2002-08-22 | Sueddeutsche Kalkstickstoff | METHOD FOR PRODUCING BIOLOGICALLY ACTIVE POLYMERNANOPARTICLE-NUCLEIC ACID CONJUGATES |
DE19753298A1 (en) * | 1997-12-01 | 1999-06-02 | Basf Ag | Process for the preparation of solid dosage forms |
DK172900B1 (en) * | 1998-12-18 | 1999-09-27 | Per Julius Nielsen | Preparation and kit for use in intraocular surgery |
SG187547A1 (en) * | 2011-03-18 | 2013-03-28 | Seed Co Ltd | Medical device for controlled release of drug |
JP2017080303A (en) * | 2015-10-30 | 2017-05-18 | 日油株式会社 | Medicine sustained release medical use contact lens |
MX2020004666A (en) | 2017-11-17 | 2022-01-26 | Cellix Bio Private Ltd | Compositions and methods for the treatment of eye disorders. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2229984A1 (en) * | 1972-06-20 | 1974-01-10 | Kraemer Kg Wilhelm | FASTENING DEVICE FOR A BATTERY-FEED WARNING LAMP |
DE2246037B2 (en) * | 1972-09-20 | 1975-02-27 | Taeschner & Co, 8831 Kipfenberg | Orally applicable drug with delayed absorption in suspension form |
-
1976
- 1976-08-12 IL IL50250A patent/IL50250A/en unknown
- 1976-08-13 DE DE2636559A patent/DE2636559C2/en not_active Expired
- 1976-08-23 SE SE7609339A patent/SE7609339L/en unknown
- 1976-08-26 JP JP51101173A patent/JPS5254014A/en active Pending
- 1976-08-27 CH CH1090876A patent/CH621940A5/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE2636559A1 (en) | 1977-03-17 |
SE7609339L (en) | 1977-02-28 |
CH621940A5 (en) | 1981-03-13 |
DE2636559C2 (en) | 1985-10-31 |
JPS5254014A (en) | 1977-05-02 |
IL50250A (en) | 1980-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL50250A0 (en) | Pharmaceutical base salts of a polymer containing acid | |
ZA761413B (en) | Preparation of solution polymers | |
FR2326934A1 (en) | NEW PHARMACEUTICAL COMPOSITION BASED ON SERUM-ALBUMIN SPHERULES CONTAINING A MEDICINAL PRODUCT | |
SE433804B (en) | PROCEDURE FOR PREPARING A PHARMACEUTICAL PHARMACEUTICAL PREPARATION | |
US6031093C1 (en) | Solid salts of clavulanic acid | |
JPS5212134A (en) | Compositions containing organicctitanic acid salts | |
NZ180552A (en) | Pharmaceutical preparation containing a rigid macrom-orphological structure and a carbonxylic polymer or a salt there of | |
NO146044C (en) | PROCEDURE FOR PREPARING A PHARMACEUTICAL INSULIN PREPARATION FOR RECTAL USE | |
BE827677A (en) | CAPSULE COATING PROCESS | |
ZA766183B (en) | New phenoxyalkylcarboxylic acid derivatives | |
ZA765531B (en) | New phenoxyalkylcarboxylic acid derivatives | |
YU126276A (en) | Process for preparing new propargyl-2-phenylamino-imidazolines-(2) and acid addition salts thereof | |
IL52433A0 (en) | A novel 2-phenylimino-imidazolidine derivative and salts thereof their preparation and pharmaceutical compositions containing them | |
FR2310800A1 (en) | HYDROGEL-BASED PERFUME-DEODORANT | |
FR2325374A1 (en) | NEW BASIC SUBSTITUTE PYRIDINECARBOXAMIDES USEFUL AS MEDICINAL PRODUCTS | |
HU173475B (en) | Process for preparing a stable pharmaceutical preparation containing watre-soluble salts of parenterally applicable dehydro-epi-androsterone-sulphate | |
ZA762088B (en) | Carboxylic acid amides a process for their preparation and their use as medicaments | |
FR2307541A1 (en) | MEDICINAL PRODUCT BASED ON A POLYPEPTIDE | |
FR2313075A1 (en) | MEDICINAL PRODUCT BASED ON L-PYROGLUTAMYL-L-HISTIDYL-L-PROLINAMIDE OR ITS SALTS | |
ZA76150B (en) | Pharmaceutical ferrocene compound | |
JPS5285126A (en) | Novel phenetylamine derivatives* salts thereof and pharmaceutical composition | |
IL47103A0 (en) | 5-oxo-5h-dibenzo(a,d)-cycloheptene-2-acetic acid derivatives and salts and esters,their preparation and pharmaceutical compositions containing them | |
JPS5219650A (en) | Novel diaminooandrostane derivatives * acid adduct salts * quartanary salts and preparation thereof | |
NZ182807A (en) | Pharmaceutical compsoitions containing benzoic acid derivatives | |
NZ181107A (en) | 16-hydroxycarbyloxy-16-deacet-oxyfusidic acid derivatives and analogs thereof |